siRNA treatment lowers triglycerides in patients along with uncommon problem

.RESEARCH STUDY EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride degrees by 80% as well as decreased the risk of pancreatitis in individuals along with persistent chylomicronemia, along with or without a hereditary diagnosis.